La Jolla Pharmaceutical Company (LJPC) News

Innoviva to Acquire La Jolla Pharmaceutical Company
https://finance.yahoo.com/news/innoviva-acquire-la-jolla-pharmaceutical-113200698.html

If you read 10-k, they show additional $5m in buyback. So far ( to date) they purchased less than $4m .. should move higher especially if they can increase sales and or M&A

LJPC) today announced that it will commence a share repurchase plan for up to $10 million of the Company’s common stock. Repurchases may be made from time to time at the Company’s discretion. The plan has no time limit and can be discontinued at any time.

It’s happening, higher base

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress

https://www.businesswire.com/news/home/20210805005263/en/

Maybe we can get some extraordinary top-line growth with both of our commercialized drugs! Wish Mgmt would do CC after eps release!! Talk about new drugs in the pipe.

???

KT’s appetite never ends! He gobbling up all the shares and soon will be close to 50%??

Apparently not enough

Tang sending it

WTF

Thanks Bud, GL

https://www.google.com/amp/s/www.analystratings.com/articles/la-jolla-pharma-ljpc-receives-a-buy-from-chardan-capital/amp/

By whom?

Upgraded today. $15 PT

Good to know! I looked at Earnings Whisper and it said 15th go figure

Not much movement from it though

They reported this morning.... beat on revenue. More cost reductions. Have over $40 million in cash now. Looking good on the balance sheet and growing revenue every quarter

March 15th before the open

Is/Are today the Financials are released Q4, Annual? Any guidance, Conf call please!!

Tang has a lot going on with different tickets. I assume he has some grand plan to bring it all together. Maybe he’s not ready yet to share. I’m kinda a believer that he has a chance to bring significant value here

Totally agree! Would be great if we could get some sell side analysts involved! Communication from MgMt ( conferences, ‘fire side’ chats helpful

Maybe he will. Never know. They’re going to eventually have to start addressing investors more. I’ve been very pleased with my returns here but I believe this can really break out higher

Agreed! Good volumes last couple days, Blackrock filing 13g, etc..Just wish new CEO would do Q&A after EPS release next month

Been really nice since announcing that $100+ million dollar deal last month. Prob something more going on here now. Expect news soon

Nice movement ??

Nice movement here lately. Push for $10+ coming?

Maybe w/ just Gia, I’m thinking same template like Paion( both
Giapreza and Xerava Together)..we shall see soon, hopefully sales gained some traction here in the states??
Been a slow ramp up w/ Just Gia

Already exists doesn’t it? Everest medicine ..... should have an update on that anytime.

Also interesting it had such a large volume of shorts on that spike on the news on Jan 12th. Yet it’s held gains and is going back up on relatively low volume. Could squeeze them

Or maybe Asian licensing agreement like recent EU collaboration?
International expansion now that we have a real CEO

Tang prob buying more today

Agreed! Finally starting to build out business internationally!
Tang owns 30+%, low floater

10$ coming. worth 17$

Shhhh, she’s a blessing on everything she touches lately, lol ?? ?? any where from 35-200% higher once the “Charts’ are posted ??

Swing and a miss on that assessment?

Same here Star, almost picked off 2000 more at $4.10 as news hit , missed it ! Lol

I love this lady CT??

* * $LJPC Video Chart 01-12-2021 * *

Link to Video - click here to watch the technical chart video

Yes indeed, I have been loaded since the Covid crash and ready for take off back to $20's

Finally management exists and working for US!!

It has to be some kind of merger so the Company closed the headquarter, no employees and Auctioned all the equipments. We may get an updates any day.

Yeah I don’t disagree. Public company’s are supposed to be more transparent than this. But I’m sure there’s something big in the works behind the curtains here and it will be revealed, eventually.

that's not how you run a publicly traded company (especially mkt caps of $100mm+).. that's why we have 0 sell/buy side analysts..we have a great story to tell, but it's falling on deaf ears, imho..nonetheless, somethings up:)

I honestly don’t care how transparent they are. I’m sure they’ll share news when they have it. No way Tang is putting that much on the line and buying up the float for nothing. Something is up here for sure.

agreed! just wish they were more shareholder friendly but perhaps with Edwards as new CEO, they will hold qtrly conf calls. the previous CFO and i would speak occasionally, but of course nothing 'insider' based... they did have high hopes on the malaria drug( more for voucher reasons-could have been worth 100mm+) but that went to competing private company.. maybe Kevin and Edwards can buy them, lol.. glta

Has to be something good in the works here with all this insider buying. The tetraphase buyout looks promising as well. Interesting news with them letting the contract for their facility expire. Could be a buyout or something else like a merger etc. I’m in this heavily, I see too much potential.

Yes, about 35% and climbing especially in the 3’s..we also have Director Ramsay buying albeit small but that says something! Now if we see Larry Edwards and other directors, then something big down the pike!

Kevin Tang owns what now like 35-40% of this company? And he keeps buying

What are the chances that Ljpc Hq moves to Tetra’s HQ in Massachusetts?

No one at La Jolla is working on a Coronavirus vaccine??????????????????

Pitiful!

Let's go bitches! Get with the program!

$LJPC La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2019

GlobeNewswire GlobeNewswire•March 2, 2020

For the three months ended December 31, 2019, GIAPREZA U.S. net sales were $7.3 million, up 74% from the three months ended December 31, 2018 and up 28% from the three months ended September 30, 2019. Vials of GIAPREZA shipped from distributors to hospitals (hospital demand) grew 74% for the three months ended December 31, 2019 as compared to the three months ended December 31, 2018 and 18% as compared to the three months ended September 30, 2019. GIAPREZA U.S. net sales were $23.1 million in 2019 compared to $10.1 million in 2018, an increase of 129%. La Jolla announced the commercial availability of GIAPREZA in the U.S. in March 2018.

La Jolla’s net loss for the three and twelve months ended December 31, 2019 was $25.2 million and $116.5 million, or $0.93 per share and $4.30 per share, respectively, compared to $45.4 million and $199.5 million, or $1.73 per share and $7.85 per share, respectively, for the same periods in 2018.

As of December 31, 2019, La Jolla had $87.8 million in cash, compared to $172.6 million as of December 31, 2018. Net cash used in operating activities for the three and twelve months ended December 31, 2019 was $17.1 million and $85.0 million, respectively, compared to $32.0 million and $152.4 million, respectively, for the same periods in 2018. La Jolla has no debt.

https://finance.yahoo.com/news/la-jolla-pharmaceutical-company-announces-133010981.html